In recent years, an increasing number of Bartonella species have been identified as zoonotic pathogens, transmitted by animal bites, scratches, arthropods and even by needle sticks. Considering the diversity of newly discovered Bartonella species and subspecies and the large number and ecologically diverse animal reservoir hosts and the evolving spectrum of arthropod vectors that can transmit these bacteria among animals and humans, the clinical and diagnostic challenges posed by Bartonella transmission in nature are presumably much more complex than is currently appreciated by diagnosticians, vector biologists, ecologists, physicians, or veterinarians. Historically the term "bartonellosis" was attributed to infections with Bartonella bacilliformis, transmitted by sandflies in the Peruvian Andes. Currently, however, bartonellosis now includes infections caused by any Bartonella sp. anywhere in the world. Potentially, because Bartonella spp. can infect erythrocytes, endothelial cells, pericytes, CD34 + progenitor cells, and various macrophage-type cells, including microglial cells, dendritic cells, and circulating monocytes in vitro, the clinical and pathological manifestations of bartonellosis appear to be very diverse in both sick animals and human patients. Because 75% of emerging infectious diseases are zoonoses, many of which are vector-transmitted by an arthropod, a One Health approach to bartonellosis and other zoonotic infections is needed to properly address animal health, public health, and environmental factors that influence the distribution and transmission of these bacteria. The One Health concept encourages a spirit of cooperation among animal, environmental, and human health professionals and promotes developing integrated solutions for complex problems that impact the health of animals, humans, and the planet. Importantly, substantial research is needed to define the medical importance of this genus as a cause of animal and human illnesses.
Introduction

B
ecause of rapid changes in microbiological, pathophysiological, and medically relevant information regarding bartonellosis, One Health professionals, including ecologists, environmentalists, microbiologists, physicians, vector biologists, and veterinarians, have published numerous authoritative reviews during the past two decades, of which a subset are cited (Billeter et al. 2008; Boulouis et al. 2005; Breitschwerdt and Kordick 2000; Breitschwerdt et al. 2010a; Chomel et al. 2006; Harms and Dehio 2012; Kaiser et al. 2011; Minnick and Battisti 2009) . Bartonella species are recently rediscovered, fastidious, Gram-negative, vectorborne bacteria that are highly adapted to one or more mammalian reservoir hosts and within which these bacteria have most probably coevolved to cause a long-lasting, relapsing, intraerythrocytic bacteremia (Harms and Dehio 2012; Kaiser et al. 2011) . Each of these factors is of particular importance to physicians, veterinarians, and other public health professionals because an increasing number of animal reservoir hosts and a diversity of arthropod vectors have been identified for both the environmental maintenance and competent transmission of various Bartonella species (Table 1) . Among numerous other examples, Bartonella henselae has coevolved with cats, Bartonella vinsonii subsp. berkhoffii has coevolved with dogs and wild canines, Bartonella bovis has coevolved with cattle, Candidatus Bartonella melophagi has coevolved with sheep, and Bartonella australis has coevolved with kangaroos (Chomel et al. 2006; Guy et al. 2013) . Thus, a diversity of Bartonella spp. have most likely coevolved with specific animal species and the arthropods that have historically infested these animals. Importantly, the list of mammalian reservoir-adapted Bartonella species, including an extremely large number of rodent-adapted Bartonella spp. that might serve as "pocket pets," continues to grow exponentially as new Bartonella spp. have been discovered (Buffet et al. 2013) . Examples of closely related rodent Bartonella spp. include proposed Candidatus species that have coevolved with ground squirrels (Candidatus Bartonella washoensis), gray squirrels (Candidatus Bartonella durdenii), flying squirrels (Candidatus Bartonella volans), and ground hogs (Candidatus Bartonella monaxi). Most recently, a diversity of novel Bartonella spp. have been identified in insectivorous and frugivorous bats, which may ultimately prove to be of zoonotic, One Health importance (Bai et al. 2012b; Mühldorfer 2013) . It is also increasingly obvious that bats have coevolved with a large number of bacterial and viral zoonotic pathogens, further increasing the medical importance of bat bites and, potentially, exposure to bat guano (Mühldorfer 2013) .
Before 1990, there was only one named Bartonella species (B. bacilliformis), whereas there are now at least 30 named and numerous yet to be named or Candidatus species. Seventeen Bartonella spp. have been associated with an expanding spectrum of animal and human diseases (Breitschwerdt et al. 2010a; Harms and Dehio 2012; Kaiser et al. 2011) . Considering the diversity of newly discovered Bartonella species and subspecies, the large number and diversity of animal reservoir hosts, and the spectrum of transmission competent and implicated arthropod vectors, the clinical and diagnostic challenges posed by Bartonella transmission in nature are presumably much more complex than is currently appreciated by microbiologists, physicians, veterinarians, and vector biologists Mascarelli et al. 2013 ).
Historical Highlights
Although historically the term "bartonellosis" was attributed to infections with B. bacilliformis, transmitted by sandflies (genus Lutzomyia) in the Peruvian Andes, a more inclusive medical use of this term now includes infections caused by any Bartonella sp. anywhere in the world. Before 1990 and the discovery of the AIDS virus, Bartonella spp. were not Human, dog [myocarditis, endocarditis] recognized as animal or human pathogens in North America and, to a substantial degree, throughout the world. During the early years of the AIDS epidemic, bacteria were histopathologically visualized with silver stains within bacillary angiomatosis and peliosis hepatis lesions (i.e., vasoproliferative lesions within the skin or liver, respectively) of immunocompromised individuals (Koehler et al. 1997; Moulin et al. 2012; Relman et al. 1992) . Because initial efforts to isolate these bacteria were unsuccessful, Dr. David Relman and colleagues (1992) at Stanford University amplified 16S rDNA sequences from bacillary angiomatosis tissues that were consistent with Bartonella quintana and a second, not previously described bacterium, which ultimately was shown to be B. henselae, and subsequently shown to be the cause of cat scratch disease (CSD). Historically, two medically important Bartonella spp. (i.e., B. bacilliformis and B. quintana) predated the "rediscovery" of Bartonella spp. as a cause of animal and human diseases in North America and throughout the world. Subsequently, the association of B. henselae with CSD by Russ Regnery at the Centers for Disease Control and Prevention in Atlanta, Georgia, resulted in the recognition that numerous cats throughout the world were B. henselae bacteremic and that Ctenocephalides felis (the "common" cat flea) was responsible for bacterial transmission among cats (Pennisi et al. 2013; Zangwill 2013) In addition, circumstantial historical evidence supports the potential that flea bites (cat, dog, and rodent fleas) may result in direct transmission of several Bartonella spp. to humans (Bouhsira et al. 2013; McElroy et al. 2010) . Importantly, recent in vitro evidence supports the ability of five Bartonella species to persist in C. felis, suggesting an ability of the common cat flea to be a potential vector for several Bartonella species (Bouhsira et al. 2013; Yore et al. 2014) . In the context of other recent research observations and daily medical practice, it seems likely that cat flea transmission of pathogenic Bartonella spp. throughout much of the world poses a substantially greater infectious disease risk for animals and humans than is currently appreciated. Recent experimental laboratory evidence also indicates that the routine use of an acaracide product can interrupt flea transmission of B. henselae to cats, which would prevent cat transmission of these bacteria to humans (Lappin et al. 2013) . Currently, no vaccines are available to prevent Bartonella infections in animals or humans.
Carrion's Disease
Although archeological evidence supported infection in indigenous Peruvians hundreds of years earlier, infection with B. bacilliformis was first published in 1909 by Alberto Barton (Sanchez Clemente et al. 2012 ). This bacterium causes both an acute febrile illness (Carrion's disease or Oroya fever) and a chronic vasoproliferative disease (verruga peruana) and is primarily diagnosed in people from Peru, Ecuador, and Columbia, but it has also been described in travelers to South America months to years after returning to nonendemic countries. In the acute illness, usually (Brouqui and Raoult 2006) . B. quintana DNA has been amplified from cat fleas, and the bacteria was isolated from a woman residing in North Carolina and from the feral cat that induced her bite wound, supporting the possibility of cat bite transmission of this Bartonella sp. and human infection by modes other than body louse exposure ).
Cat Scratch Disease
For more than a century, fever and regional lymphadenopathy have been associated with animal contact, particularly cat scratches (Zangwill 2013 (Anderson et al. 1994) . A similar study from Sweden identified B. henselae DNA, but failed to identify A. felis DNA (a historically proposed cause of CSD), in a large number of patients with suspected CSD. Subsequently, we cultured B. henselae or Bartonella clarridgeae from the blood of 17 of 19 cats owned by 14 CSD patients weeks to years after CSD was diagnosed in the owner or bite/scratch victims, which indicated that chronic bacteremia is a frequent occurrence in cats that transmit B. henselae to a human being (Kordick et al. 1995) . However, recent microbiologic evidence indicates that the most common B. henselae genotypes found in bacteremic cats are not the same genotypes found in CSD patients, suggesting that only a subset of the more virulent B. hensleae strains found in cats causes acute CSD (Chaloner et al. 2011) . Historically, atypical manifestations of CSD have included tonsillitis, encephalitis, cerebral arteritis, transverse myelitis, granulomatous hepatitis and/or splenitis, osteolysis, pneumonia, pleural effusion, and thrombocytopenic purpura. With the advent of more specific and sensitive diagnostic techniques (culture, serology, PCR, enrichment culture/PCR), there has been a dramatic increase in reports describing human patients with "atypical" manifestations of CSD, suggesting that these atypical manifestations occur much more commonly than was historically suspected (Giladi et al. 2005; Zangwill 2013 ). In particular, osteomyelitis, granulomatous hepatitis, and granulomatous splenitis have been increasingly recognized in children and adults infected with B. henselae. A large subset of these patients lacks the classical fever and lymphadenopathy associated with typical CSD. Therefore, until recently, Bartonella infection would not have been considered a likely differential diagnosis by a physician in patients lacking a history of fever, lymphadenopathy, and cat contact. As evidenced by reports in the past 4 years, the spectrum of human disease associated with the genus Bartonella continues to expand, requiring periodic reassessment as new information becomes available (Breitschwerdt et al. 2010a; Harms and Dehio 2012; Kaiser et al. 2011; Zangwill 2013) . On a comparative medical (One Health) basis, our research group has documented many of the same human atypical CSD manifestations in sick cats or dogs, including encephalitis, transverse myelitis, granulomatous hepatitis, osteolysis, pleural effusion, and thrombocytopenic purpura (Breitschwerdt et al. 2010a; Cherry et al. 2009; Varanat et al. 2009 ). In the context of One Health, the atypical manifestations of a highly prevalent, naturally occurring human disease (CSD) were used as a naturally occurring model to determine the potential behavior of the genus Bartonella in companion animal patients (cats and dogs), ultimately resulting in documentation of comparable pathologies.
Typical CSD historically denotes a self-limiting illness characterized by fever and lymphadenopathy, temporarily associated with a cat scratch or bite. Because of the recognized spectrum of human disease manifestations associated with bartonellosis (which does not consistently include fever, lymphadenopathy, or a history of an animal bite or scratch) and because a subset of CSD patients develop persistent bacteremia, it is becoming obvious that although a commonly used term in the clinical setting, the designation CSD has much more limited clinical, microbiologic, and zoonotic utility than could be appreciated a few short years ago. Although cats are a major reservoir for B. henselae, B. clarridgeiae, and Bartonella koehlerae, some CSD patients deny the possibility of a cat scratch or bite wound or indicate no contact with cats. Clinical evidence indicates that transmission of B. henselae from environmental sources (historically CSD was associated with rose thorn scratches and B. henselae is viable in flea feces for at least 7 days), transmission by various arthropod vectors (Maggi, Ericson, et al. 2013; Mascarelli et al. 2013) , perinatally (Breitschwerdt et al. 2010b ), or by other animal hosts (Beard et al. 2011; Maggi et al. 2008 ) is probable; therefore, from an educational and clinical perspective, the more inclusive term bartonellosis may facilitate more rapid future understanding of the pathophysiology, clinical diagnostic paradigms, and diseases caused by members of the genus Bartonella. Because physicians have been taught that CSD is self-limiting, there is an ongoing lack of appreciation that B. henselae can cause chronic, asymptomatic, minimally symptomatic, or intermittently symptomatic illnesses, accompanied by persistent bacteremia, in people. In this context, the documentation of chronic, relapsing bacteremia in cats (Kordick and Breitschwerdt 1997) and experimentally infected rodent species (Schülein et al. 2001) provides models for enhanced understanding of the potential microbiological aspects of human bartonellosis.
Bartonella Endocarditis
Before 1993, Bartonella spp. had never been implicated in or associated with endocarditis in animals or human patients (Chomel et al. 2009 ). Subsequently, since 1993, endocarditis has been associated with a spectrum of Bartonella spp., particularly in dogs and human patients. In the context of disease causation, endocarditis has now been associated with nine and seven Bartonella spp. in humans and dogs, respectively, thereby supporting an important pathological role for this genus of bacteria in immunocompetent animals and human patients (Lamas et al. 2013) . Historically, because of the highly fastidious nature of these bacteria, Bartonella spp. were a cause of culture-negative endocarditis in dogs and people.
Culture-negative endocarditis is diagnosed when echocardiography or valvular histopathology readily documents a heart valve infection but bacteria are not successfully isolated from the patient's blood or valvular tissue. In most instances, historical diagnostic methods used by microbiology laboratories were not adequate to isolate these bacteria. Clearly, successful isolation of Bartonella spp. from bacteremic animal and human patients remains an ongoing challenge. However, by using specialized isolation and PCR amplification techniques, research and diagnostic laboratories throughout the world have identified a spectrum of Bartonella spp. in reservoir hosts, known and potential vectors, and animal and human patient samples. PCR amplification of Bartonella spp. DNA from heart valves or blood culture isolation of these bacteria from dogs and people with echocardiographic evidence of endocarditis has substantially contributed to the expanding spectrum of medically important Bartonella spp. that are capable of inducing disease. From a One Health perspective, it is important for physicians to recognize that those Bartonella spp. implicated in association with human endocarditis have been found in the blood of cats, dogs, rats, ground squirrels, rabbits, and numerous other animals, many of which serve as persistently bloodstream-infected reservoir hosts and a source of vector transmission and inadvertent human infection (Chomel et al. 2009 ). Medically, it is imperative for clinicians to obtain a detailed travel history because many Bartonella spp. have regional differences in prevalence or occurrence. Also, patient histories should include questions relative to prior exposure to animals and arthropod vectors that infest various animals, particularly rodent and cat fleas, lice, and ticks.
Veterinary Medical Importance
Although the literature is not exhaustive, the clinical and pathological manifestations of bartonellosis in animals (Breitschwerdt et al. 2010a; Pérez Vera, Diniz, et al. 2013) and humans Florin et al. 2008; Lamas et al. 2008 ) have been reviewed. Pet cats and dogs often develop very similar or the same disease manifestations as human patients (Beerlage et al. 2012; Breitschwerdt et al. 2010a; Chomel et al. 2009 ). Because of extensive contact with a spectrum of healthy and sick animal species, veterinary and other animal health professionals appear to have an occupational risk of infection Breitschwerdt et al. 2010c; Breitschwerdt et al. 2010d . Because of frequent exposure to Bartonella spp., these individuals should exercise increased precautions to avoid arthropod exposure (i.e., fleas and lice), animal bites or scratches, and direct contact with bodily fluids, particularly from, but not limited to, sick animals. After putative needle stick transmission of a Bartonella sp., headache, fatigue, and intermittent paresthesia have been reported in a veterinarian from the United States (Oliveira et al. 2010 ) and fever of unknown origin and back pain were reported another veterinarian from Taiwan (Lin et al. 2011 ). In the US veterinarian, all symptoms resolved after antibiotic treatment. Complex regional pain syndrome occurred in a veterinarian, seemingly accompanied by a positive therapeutic response to antibiotics (Pérez Vera et al. 2014) . Because Bartonella spp. have been isolated from cat and dog blood, cerebrospinal fluid, joint fluid, aqueous fluid, seroma, and pleural, pericardial, and abdominal effusions, a substantial number of diagnostic biological samples collected on a daily basis in veterinary practices could contain viable Bartonella sp. bacteria. The increasing number of defined Bartonella spp. found in the typical veterinary patient population (cats, dogs, cows, horses, rodents, and other animals) ensures that most veterinary professionals will experience frequent and repeated exposure to animals harboring these bacteria. In addition, there is increasing evidence to support coinfection with B. henselae and other bacterial pathogens that induce potentially persistent bloodstream infections in human patients (Cadenas et al. 2007; Maggi, Compton, et al. 2013; Sykes et al. 2010) . Therefore, personal protective equipment, frequent hand washing, and avoidance of cuts and needle sticks have become more important for animal health professionals and others with frequent animal contact, as our knowledge of this genus has improved and various modes of transmission have been better defined.
Human Health Importance
A complete review of novel discoveries related to human bartonellosis is beyond the scope of this article. Because research from my laboratory was among the first to confirm longstanding bacteremia with pet-associated Bartonella spp. in nonimmuncompromised human patients, our research findings were clearly unexpected and novel and, as a result, became controversial. Work from Dr. Michael Kosoy's Laboratory and Didier Raoult's Laboratory is also highlighted herein. Important observations from many other clinicians and research groups around the world are acknowledged but cannot be considered because of space limitations.
Initially, we described B. quintana bacteremia in a woman who was tested after the development of an infected cat bite lesion involving the hand . Two months later, the feral cat that had induced the bite wound was captured and was also shown to be B. quintana bacteremic. In a cumulative study involving 392 patients with occupational animal contact or extensive arthropod exposure , 31.9% were bacteremic with one or more Bartonella spp. when blood, serum, and Bartonella alpha Proteobacteria growth medium (BAPGM) enrichment culture PCR results were combined. Although this high prevalence of bacteremia is biased by testing at-risk, sick individuals using a sensitive enrichment culture/PCR/DNA sequencing approach, it clearly demonstrates that intravascular infection with Bartonella spp. is much more common in nonimmunocompromisted people than was previously suspected. By immunofluorescent antibody testing, only 75 of 128 (58.6%) PCR-positive individuals were seroreactive to a panel consisting of five Bartonella sp. test antigens. Seronegative Bartonella sp. bacteremia appears to be a common and, as yet, unexplained entity in cats, dogs (Perez et al. 2010) , and human patients . Coinfection with B. henselae and a hemotropic Mycoplasma, similar or identical to Mycoplasma ovis, were also found in the blood of a veterinarian with a historical diagnosis of multiple sclerosis (Sykes et al. 2010) . In another study, Bartonella vinsonii subsp. berkhoffii, Bartonella henselae, or DNA of both organisms was amplified and sequenced from blood, BAPGM enrichment blood cultures, or autopsy tissues from four family members. Historical and microbiological results derived from this family supported the possibility of human perinatal transmission of Bartonella spp. (Breitschwerdt et al. 2010b) . Interestingly, the parents of these children, both infected with the same Bartonella sp. and genotype had attempted to conceive children for several years before resorting to in vitro fertilization. To date, there have been a limited number of studies that address the potential impact of intravascular infection with a Bartonella sp. on reproductive performance; however, from a One Health perspective, studies involving experimentally infected cats, rodents, and naturally infected cows with various Bartonella spp. have identified a spectrum of reproductive abnormalities, including decreased reproductive performance involving both male and female cats (Guptill et al. 1998 ). In the context of Bartonella spp. and vasoproliferative pathologies, B. vinsonii subsp. berkhoffii genotype II was amplified and sequenced from a liver biopsy from a young man with epithelioid hemangioendothelioma, after which the organism was isolated by BAPGM blood culture ). Subsequently, B. henselae and B. koehlerae DNAwas documented in two additional epithelioid hemangioendothelima patients, one residing in Australia and the other in England. ) Bartonella spp. also appear to be associated with vasoproliferative tumors in animals (Beerlage et al. 2012) . The unique capability of Bartonella to invade and induce long-lasting intraerythrocytic and intraendothelial infections, in conjunction with the ability of at least four Bartonella spp. (B. henselae, B. quintana, B. bacilliformis, and B. vinsonii subsp. berkhoffii) to induce VEGF-mediated vasoproliferative disease in immunocompromised or immunocompetent cats, dogs, humans, and other animals, suggests that these novel emerging bacterial pathogens might contribute to the development of vascular lesions, including vascular tumors in immunocompetent animal and human patients. On a One Health basis, satisfying the Postulate of Comparative Infectious Disease Causation for Bartonella spp. and vasoproliferative tumors may facilitate more rapid medical progress relative to Bartonella spp. and oncogenesis involving the vasculature.
Although infrequently implicated as a cause of human infections, B. koehlerae bacteremia was documented in eight immunocompetent patients by PCR amplification and DNA sequencing, either before or after BAPGM enrichment blood culture (Breitschwerdt et al. 2010d) . Presenting symptoms among these eight patients most often included fatigue, insomnia, joint pain, headache, memory loss, and muscle pain. Although these symptoms are nonspecific and can be associated with numerous infectious and noninfectious diseases, similar symptomatology has been reported in bartonellosis patients in two subsequent case series Maggi et al. 2012) . Four B. koehlerae bacteremic patients were also infected with B. vinsonii subsp. berkhoffii genotype II, which may be related to flea transmission of both of these bacteria (Yore et al. 2014) . Bartonella koehlerae antibodies were not detected (titers < 1 : 16) in 30 healthy human control sera, whereas five of eight patient samples had B. koehlerae antibody titers of 1 : 64 or greater. In a subsequent case report, persistent B. koehlerae bactermia was documented in a young woman with hallucinations, peripheral visual loss, and a sensory neuropathy ) and in a veterinarian diagnosed with complex regional pain syndrome (Pérez Vera et al. 2013) . Based upon these case reports and case series, long-term prospective case-control studies are needed to determine whether B. koehlerae, B. henselae, and other Bartonella spp. are a cause or cofactor in the development of arthritis, peripheral neuropathies, or tachyarrhythmias in human patients.
Dr. Michael Kosoy's research group at the Centers for Disease Control and Prevention has investigated zoonotic Bartonella spp. infections in patients from Thailand. DNA of numerous rodent Bartonella spp., including Bartonella tamiae, Bartonella elizabethae, Bartonella tribocorum, Bartonella rattimassilensis, and B. vinsonii subsp. arupensis, was found in febrile patients who reported recent rodent contact, followed by fever, myalgia, dizziness, headaches, and fatigue ). In addition to also documenting human Bartonella endocarditis (B. henselae) in Thailand, infection with B. vinsonii subsp. arupensis was also reported in three febrile patients and another nonfebrile patient whose symptoms included joint pain, abdominal pain, fatigue, myalgia, and cough (Bai et al. 2012a ). Because B. vinsonii subsp. arupensis and other rodent-associated Bartonella spp. found in febrile human patients were previously described in bacteremic dogs , the vector ecology and transmission dynamics of these bacteria among dogs and humans deserve additional research consideration, further emphasizing a One Health approach to bartonellosis as an emerging infectious disease.
Publications from Professor Didier Raoult's research group have provided insights into the human medical importance of Bartonella spp. in Europe and other parts of the world. Repeatedly, his laboratory has defined an important role for B. quintana and B. henselae as a cause of culture-negative endocarditis (Casalta et al. 2009 ). In addition, the laboratory reported cases of generalized granulomatous lymphadenitis (CSD) in association with B. henselae. Both endocarditis and granulmoatous lymphadenitis were subsequently associated with human B. alsatica infections in France, most likely due to transmission from rabbits, the reservoir host for this Bartonella sp. to humans (Jeanclaude et al. 2009 ). In a recent publication, 340 of 1688 (53%) lymph nodes from lymphadenitis cases examined at a major referral hospital in France between 2008 and 2012 contained B. henselae DNA (Safont et al. 2014) . As discussed herein, the association of infection with Bartonella spp. and vasoproliferative lesions (bacillary angiomatosis and peliosis hepatis) in immunocompromised AIDS patients precipitated research investigations, now spanning more than two decades. Recent reports indicate that bartonellosis is a concern for solid organ transplant recipients (Moulin et al. 2012; Rostad et al. 2012 ) and patients receiving immunosuppressive drugs for treatment of autoimmune and immune-mediated diseases (Mathieu et al. 2007; Milin et al. 2013 ). There are also recent case reports describing B. henselae infection mimicking autoimmune disease (Maritsi et al. 2013) , potentially triggering autoimmune thyroiditis in a child (Chiuri et al. 2013) .
The spectrum of symptoms and pathology reported in patients with bartonellosis continues to expand much more rapidly than our understanding of the pathophysiology of many of these disease manifestations. This overview is in no way comprehensive in the context of the evolving literature related to this genus of bacteria but illustrates several major trends related to this emerging pathogen.
Vectors, Environment, Pathogens, and Disease
Epidemiological evidence and experimental transmission studies support an important role for fleas (C. felis) in the transmission of these bacteria among cats, dogs and other small mammals throughout much of the world (Billeter et al. 2008) . C. felis transmits B. henselae, B. clarridgeae, B. koehlerae, and potentially B. quintana Kernif et al. 2014) ; thus this common ectoparasite should be considered a major source of zoonotic Bartonella sp. transmisison. Currently, in the context of a global health threat, flea infestations on pets and feral and wild animals are medically underappreciated as a source of Bartonella sp. transmission and as a cause of animal and human suffering/ disease. Cats can be chronically bacteremic with four zoonotic Bartonella spp. for months to years after flea transmission, making flea-exposed cats a major reservoir for human infection. In addition to fleas, an increasing number of arthropod vectors, including biting flies, keds, lice, mites, sandflies, spiders, and ticks have been implicated in the transmission of Bartonella spp. (Billeter et al. 2008 , Previte et al. 2014 . Wood louse hunter spider bite transmission of B. henselae may have resulted in neurological disease manifestations in three members of a family in Kentucky . Collectively, there are many deficiencies in our understanding of vector competence and mode(s) of Bartonella sp. transmission.
Need for a One Health Approach to Bartonellosis
One of the most pressing requirements in the context of Bartonella research is the need to define the biological price, if any, that various animals, including humans, pay for persistent Bartonella sp. bloodstream infections. It is unlikely that the answers to this question can be generated through laboratory rodent studies, in vitro cell culture studies, or short-term infection studies. Long-term epidemiological studies or other approaches will be required, such as the recently proposed Postulate of Comparative Infectious Diseases Causation . The original and the more recently proposed molecular Koch's postulates for infectious disease causation have been historically useful, particularly when attempting to confirm that a disease is caused by a single infectious agent that induces an acute infection (frontal pathogen). Establishing disease causation in association with chronic, occult infections caused by "stealth" pathogens such as Bartonella spp. that can seemingly induce chronic, slowly progressive disease manifestations in an animal or human patient is much more difficult to achieve by applying the classical or more recently proposed molecular Koch's postulates. In contrast with stealth pathogens, frontal pathogens are characterized by an organism that has a brief incubation period and a readily defined source of exposure/infection and induces an acute illness. In addition to other obvious limitations, rodent and other laboratory-based studies do not readily allow researchers to address naturally occurring environmental, nutritional, genetic, or other medically relevant factors that influence disease causation or consider the pathogenic complexities induced by sequential or simultaneous infection with more than one pathogenic microorganisms, as occurs in nature. This is important because there is evolving evidence of coinfection with other vector-borne organisms, such as Anaplasma platys and hemotropic Mycoplasma spp. in humans infected with B. henselae (Maggi, Compton, et al. 2013; Sykes et al. 2010) . Because of these inherent limitations, a group of human and veterinary clinician scientists recently proposed the addition of a fifth Koch's postulate: Causation can be established, if the same infectious agent (or combination of agents) are isolated or organismspecific DNA sequences are amplified from a similar or identical naturally occurring pathological entity found in at least three different mammalian species. In the context of Bartonella spp., this postulate has been satisfied for chronic bacteremia, endocarditis, granulomatous inflammatory lesions, and vasoproliferative lesions of the skin and paryenchmal organs .
Because approximately 70% of emerging infectious diseases are zoonotic in nature (Sander et al. 1998) , understanding the comparative biological and pathological behavior of a specific infectious agent or combination of infectious agents across different animal species, particularly human patients and pet dogs and cats that share the same environment and potentially similar vector exposures, might provide useful indicators of chronic infectious disease causation. This is an important concept with respect to the mounting importance of the global One Health paradigm that proposes much closer integration of human and veterinary medicine (Jones et al. 2008; Taylor et al. 2001) . It is essential that cross-species infectious agents are investigated in a collaborative fashion by integrated teams of environmental, medical, and veterinary medical researchers and public health officials and that appropriate resources are allocated to permit this One Health translational research approach to comparative infectious disease causation to be successful. For zoonotic pathogens shared between animals and man, a coordinated One Health approach to investigation and application of the proposed fifth Koch's postulate might prove beneficial for animal health and human health.
Isolation and Molecular Detection of Bartonella Species
Because conventional microbiological techniques lack sensitivity, bartonellosis is usually diagnosed by PCR amplification of organism-specific DNA sequences and/or through serological testing. Recently, the development of a more sensitive isolation approach using insect cell culture-based growth medium such as BAPGM followed by PCR amplification and DNA sequencing has greatly facilitated the molecular detection or successful isolation of Bartonella spp. from the blood of sick or healthy animals, including cats, dogs, dolphins, horses, and humans (Duncan et al. 2007; Lynch et al. 2011; Riess et al. 2008) . Most important, the use of this enrichment growth medium before PCR testing has allowed our research group to confirm that nonimmunocompromised human patients, often including veterinarians and veterinary technicians, can have chronic intravascular infections with Bartonella spp. that span months to years.
It is increasingly clear that no currently available, single diagnostic strategy will confirm infection with a Bartonella sp. in all immunocompetent patients. Recent reports have identified an intraendothelial, as well as intraerythrocytic, localization for these bacteria, which represents a unique strategy for bacterial persistence. Until the development, optimization, and validation of insect cell culture medium approaches, the diagnostic detection of a Bartonella spp. in sick dogs, horses, or human patient samples was very insensitive. In fact, persistent bacteremia with B. henselae was not thought to occur whatsoever in immunocompetent human beings. As described herein, studies from our laboratory have documented persistent infection with B. henselae, B. koehlerae, and B. vinsonii subsp berkhoffii in nonimmuncompromised human patients. In one study, seroreactivity was found in only 30.4% of the patients in which Bartonella sp. infection was confirmed by PCR and DNA sequencing . Therefore, Bartonella serology lacks sensitivity and can only be used to implicate prior exposure to a Bartonella sp. Even when serum from CSD patients, which is caused by B. henselae, is used in various diagnostic laboratories for immunofluorescent antibody testing, test sensitivities have ranged 14-100% (Sander et al. 1998; Tsuruoka et al. 2012) . For the diagnostic evaluation of future animal and human patients, a panel consisting of multiple Bartonella spp. for serological assays, in conjunction with enrichment culture/PCR from blood, serum, tissues or cerebrospinal fluid, will enhance the diagnostic sensitivity and specificity needed to achieve a diagnosis of bartonellosis.
Current Trends In Bartonella Research
There are substantial, ongoing efforts to better delineate the pathogenic mechanisms by which Bartonella spp. induce disease, particularly in the context of inducing vasoproliferative vascular lesions. Recent reviews have summarized current knowledge of Bartonella pathogenesis (Ben-Tekaya et al. 2013; Harms and Dehio 2012; Kaiser et al. 2011) . Despite ongoing research efforts to better understand the pathogenesis of Bartonella sp. infections, numerous questions remain to be answered.
Establishing the molecular and biochemical pathogenesis of Bartonella-induced vasoproliferation has been a major focus for Bartonella researchers. A substantial body of literature now supports the ability of B. henselae, B. quintana, B. bacilliformis, and B. vinsonii subsp. berkhoffii to induce the production of VEGF and resultant vasoproliferation of endothelial cells (Beerlage et al. 2012; Harms and Dehio 2012; Kaiser et al. 2011 ). In the context of naturally occurring cancers, increased expression of VEGF has been documented in association with several vascular tumors, including hemangiosarcoma in dogs, epithelioid hemangioendothelioma (EHE), in human patients and hemangiopericytoma in dogs (Varanat et al. 2011) . Although causation has not been established, B. vinsonii subsp. berkhoffii genotype II was isolated from a boy with an EHE and from a dog with a hemangiopericytoma ). Subsequently, infection with B. henselae and B. koehlerae was documented in EHE patients from Australia and England and DNA of B. henselae, B. vinsonii subp. berkhoffii, or both organisms was amplified and sequenced from hemangiopericytomas in dogs, a horse, and a red wolf (Beerlage et al. 2012) . Thus, on a comparative medical or One Health basis, intravascular infection with one or more Bartonella species has been documented in EHE patients from three continents and in hemangiopericytomas from three animal species, suggesting that persistent intravascular infection with these bacteria might contribute to the development of these highly unusual and relatively uncommon vascular tumors in nonimmunocompromised people and in animals, respectively. Also, on a comparative microbiological and pathological basis, B. henselae, B. koehlerae, or B. vinsonii subsp. berkhoffii DNA has recently been amplified and sequenced from formalin-fixed and paraffin wax-embedded tissues from cats and a steer with systemic reactive angiomatosis (Beerlage et al. 2012) . This rare disease is characterized pathologically by the proliferation of vessels throughout numerous tissues within the animal's body. Collectively, the above comparative microbiological and pathological findings served as the basis for a retrospective study designed to determine whether Bartonella spp. might play a role in the pathogenesis of canine hemangiosarcoma (a malignant tumor of vascular endothelial cells that generally arises in either the spleen or the right atrium of the heart), one of the most common cancers affecting dogs (Varanat et al. 2011) . Using surgically obtained formalin-fixed and paraffin wax-embedded tissue biopsy samples from 50 dogs with splenic hemangiosarcoma, a statistically higher prevalence of Bartonella sp. DNA (26%) was found, as compared with hemotropic Mycoplasma sp. DNA (2%) or Babesia sp. DNA (6%). In addition, Bartonella sp. DNA was statistically more prevalent in the spleens of dogs with hemangiosarcoma (26%), as compared with the spleens from dogs with lymphoid nodular hyperplasia (10%). Although causation cannot be established by a geographically limited study, the comparative pathological evidence outlined above implicates a potential role for Bartonella spp. in nonimmunocompromised animals and people, including EHE in human patients, hemangiopericytoma and hemangiosarcoma in dogs, and systemic reactive angiomatosis in cats. If the association between infection with a Bartonella spp. and canine hemangiosarcoma is confirmed as causal, the development of a vaccine to prevent Bartonella sp. infections might decrease or eliminate one of the more common, serious, and potentially life-threatening malignancies affecting dogs, analogous to the papillomavirus vaccine that was recently introduced to decrease the prevalence of cervical cancer in woman. A second area of Bartonella sp. research emphasis is the identification of bacterial virulence factors. Based upon clinical and epidemiological evidence, strains of a Bartonella sp. vary in their virulence. For example, after flea transmission, highly pathogenic strains of B. henselae, for which the cat is the primary reservoir, can induce granulomatous myocarditis in young cats . Until recently, mechanisms that facilitate persistent Bartonella bacteremia in mammals were not well understood. Nonhemolytic intracellular colonization of erythrocytes in conjunction with the ability to invade and replicate within endothelial cells would preserve the organisms for efficient vector transmission, protect Bartonella from the host immune response, and potentially contribute to decreased antimicrobial efficacy (Chomel et al. 2006; Minnick and Battisti 2009 + bone marrow progenitor cells. B. vinsonii subsp. berkhoffii, B. henselae, and other Bartonella spp. have developed survival mechanisms that allow for successful infection of the host and lowlevel intravascular and intracellular persistence in the host so that the organism is available for subsequent transmission to another vector and host. These mechanisms involve interactions with both nucleated and non-nucleated host cells and are dependent on a number of virulence factors. Studies from Christoph Dehio's research group have shown that a laterally acquired type IV secretion system (T4SS; Trw) diversified among the Bartonella lineages to facilitate host-restricted adhesion to erythrocytes in a wide range of mammals (Harms and Dehio 2012) . Other studies have shown that Bartonella spp. may establish infection internal to red blood cells in a species-specific manner, but the ability to invade other cell types does not appear to be as restrictive (Harms and Dehio 2012; Houchaima et al. 2013) . This is important because Bartonella spp. are able to hide in one or more protected host niche(s) and slowly infect red blood cells over time to facilitate a persistent or relapsing intravascular infection within the host. The location of the protected host niche(s) remains a major clinically relevant question and has created some controversy among Bartonella researchers.
Other characterized virulence factors are briefly highlighted herein. Apart from the initial adherence and invasion, these virulence factors collectively contribute to the pathogenesis of Bartonella infections by modulating the immune response to allow persistence, by forming new blood vessels through endothelial cell proliferation, and by potentially influencing other as yet to be determined host cell functions.
T4SSs (VirB/D4, Vbh types) represent an elegant assembly of molecules that facilitates the efficient transfer of bacterial effector molecules to the host cell by acting as a translocation pore (Houchaima et al. 2013) . Once translocated to the host cell, these Bartonella effector proteins alter several host cell functions to the ultimate benefit of the bacteria. These Bartonella effector proteins promote invasome formation, allow for entry of Bartonella into the host cell, promote angiogenesis, and inhibit apoptosis of the infected host cell (Franz and Kempf 2011) . Certain Bartonella species within lineage 4 (including B. quintana, B. henselae, and B. vinsonii subspecies berkhoffii) also have a Trw T4SS that is critical for bacterial adherence to red blood cells and determines host specificity (Harms and Dehio 2012; Houchaima et al. 2013; Vayssier-Taussat et al. 2010 ). Much energy is required by the bacteria to form the translocation pore, thus a transcriptional regulatory system exerts control over the process. In Bartonella spp., the VirB T4SS is tightly regulated by the combination of a histidine kinase and a response regulator, known as the BatR/BatS two-component regulatory system (Houchaima et al. 2013) . Flagella are present in Bartonella spp. from lineages 1 to 3, but not lineage 4 (Houchaima et al. 2013) . As a virulence factor, flagella appear to be important in penetration of red blood cells and, potentially, attachment of the bacteria to the host cell. In addition, as studied in Volkhard Kempf's laboratory, trimeric autotransporter adhesins facilitate binding to host cell proteins. Bartonella adhesin A (BadA) is a well-known B. henselae surface protein that confers bacterial autoagglutination properties, allowing for adhesion to host cells and the extracellular matrix, and inhibits endothelial cell apoptosis as well as induces angiogenesis (Franz and Kempf 2011; Riess et al. 2007 ). As studied in Dr. Jane Koehler's laboratory, variably expressed outer membrane proteins from B. quintana also promote adhesion (through hyaluronate and vitronectin in extra cellular matrix) and facilitate angiogenesis (Minnick and Battisti 2009; Zhang et al. 2004) . Lipopolysaccharide (LPS), a component of the cell wall of most Gram-negative bacteria, from B. bacilliformis, B. henselae, and B. quintana does not activate a mammalian humoral response (Harms and Dehio 2012) . Furthermore, LPS from Bartonella quintana affects the host immune response by remaining undetectable by Toll-like receptor 4, which, when activated by LPS from other Gram-negative bacteria, results in a strong inflammatory response (Harms and Dehio 2012) . Bartonella sp. LPS has been shown to have potent anti-inflammatory properties under certain circumstances and proinflammatory properties under other conditions. Based upon limited case data , Bartonella spp. can be isolated from the cerebrospinal fluid of patients with minimal pathological evidence (i.e., increased protein and cell counts) to support inflammation or infection, perhaps due in part to the anti-inflammatory properties of Bartonella sp. LPS.
Because of persistent intravascular and intracellular infection, Bartonella sp. infections have been associated with the presence of antinuclear antibodies in dogs (Smith et al. 2004 ) and antineutrophil cytoplasmic antibodies in both dogs (Karagianni et al. 2012 ) and human patients (Satake et al. 2011) . The extent to which chronic intravascular or endotheliotropic infection contributes to immune-mediated or autoimmune (molecular mimicry) phenomena in bartonellosis patients remains unclear but deserves additional research consideration.
Future Needs in Bartonella Research
The field of Bartonella research remains in its infancy and is rich in questions, for which patient-relevant answers are badly needed. Based upon the evolving understanding of the medical importance of this genus of bacteria, basic and translational research initiatives have the potential to generate substantial benefits for animal and human health as answers to current questions are found. Based upon recent One Health observations, it is possible that directed Bartonella research could substantially reduce animal and human suffering associated with chronic debilitating disease processes. In addition, the resulting outcomes could include substantial financial healthcare savings for patients, insurance companies, and society. Some opportunities for translational research lie in developing more sensitive diagnostic assays for Bartonella spp. Diagnostic assays that provide specieslevel identification in a multiplex format would be most beneficial. Also, further improvements in culture sensitivity are needed and could be made by further defining optimal growth conditions for Bartonella clinical isolates, including length of time for culture, and by establishing the optimal frequency of patient blood draws, as indicated by one recent study . Another challenge to researchers is to develop serological assays that better balance sensitivity and specificity for various Bartonella species by using paired or sequentially collected serum samples to clearly understand the kinetics of antibody production in animal and human patients. Additional characterization of virulence factors and demonstration of their contribution to pathogenesis, as well as how members of this genus maintain persistence in the host, will further our understanding of the pathogenesis of Bartonella infections. There is also a critical need for research to elucidate the mechanism(s) by which chronic interplay between the host's immune response and the bacteria ultimately leads to disease manifestations. Perhaps even more daunting, but nevertheless critical, is to plan prospective case-control clinical studies that can provide strong evidence of cause-effect relationship (rather than disease association only) for nonspecific symptoms, as well as specific disease manifestations that can be induced by chronic Bartonella bloodstream infections in animals and humans. Studies are specifically needed to address the potential role of Bartonella spp. in a spectrum of human vascular, rheumatologic, and neurologic diseases Maggi et al. 2012) . As a specific example, the mechanisms by which some B. henselae strains cause aphasia, encephalopathy, neuropathy, seizures, or transverse myelitis should be studied. From a clinical perspective, efforts to standardize antibiotic dose and duration of treatment regimens, based upon both in vitro antibiotic susceptibility testing and patient outcome assessments are critically needed to effectively manage patients with bartonellosis. In addition, research is needed to determine whether antibiotic resistance or other factors contribute to treatment failures recently documented in some bartonellosis patients. From a One Health perspective, safe and efficacious vaccines could prevent infection in pets and thereby help to prevent infection in people.
As important, emerging, zoonotic pathogens, Bartonella spp. provide a perfect opportunity to reinforce the One Health concept (i.e., the need to integrate animal health, human health, and environmental factors) while coordinating research priorities designed to enhance diagnosis, treatment, and prevention of Bartonella spp. infections. A better understanding of the interactions of people, vectors, animals, and the environment will allow for improvements in epidemiologic and medical knowledge of the myriad disease manifestations and clinical presentations collectively known as bartonellosis.
Concluding Thoughts
During medical school, physicians, veterinarians, and other animal health professionals should be educated as to the large number of Bartonella spp. in nature, the extensive spectrum of animal reservoir hosts, the diversity of confirmed and potential arthropod vectors, current limitations associated with diagnosis and establishment of treatment efficacy, and the ecological and evolving medical complexity associated with these highly evolved, intravascular, endotheliotropic bacteria. It is critical for clinicians ( physicians and veterinarians) to consider each patient's travel history, exposures to domestic animals and wildlife, exposure to arthropod or insect vectors, and potentially whether there is a history of blood product administration. Biologists, ecologists, vector biologists, and other environmental scientists should further define the ecology, biology, and vector competence for various Bartonella spp. in nature so as to better direct the development of practical prevention strategies.
